79 related articles for article (PubMed ID: 11471894)
1. Prognostic value of the glycoprotein TAG-72 in patients with gastric cancer.
González Vitores AM; Duró GE; Fraile BB; Carrasco MA
Int J Biol Markers; 2001; 16(2):121-5. PubMed ID: 11471894
[TBL] [Abstract][Full Text] [Related]
2. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM
Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641
[TBL] [Abstract][Full Text] [Related]
3. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
4. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
[TBL] [Abstract][Full Text] [Related]
5. Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma.
González A; Vizoso F; Allende MT; Sánchez MT; Balibrea JL; Ruibal A
Int J Biol Markers; 1996; 11(3):165-71. PubMed ID: 8915712
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers and gastric cancer. TAG-72 is the most useful].
Fernández-Llamazares J; Piñol M; Encabo G; Gelonch J
Med Clin (Barc); 1998 Dec; 111(20):800. PubMed ID: 9922976
[No Abstract] [Full Text] [Related]
7. TAG-72 in gastric cancer: relationship between preoperative serum levels and tumoral content of the antigen.
Allende MT; Vizoso F; Suárez C; García I; Sanz L; García-Muñiz JL; Roiz C
Int J Biol Markers; 2000; 15(2):197-9. PubMed ID: 10883897
[No Abstract] [Full Text] [Related]
8. Serum TAG 72 levels in different human carcinomas.
Correale M; Abbate I; Gargano G; Garrubba M; Muncipinto A; Addabbo L; Colangelo D
Int J Rad Appl Instrum B; 1991; 18(1):101-3. PubMed ID: 2010293
[TBL] [Abstract][Full Text] [Related]
9. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777
[TBL] [Abstract][Full Text] [Related]
11. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
13. [CA72-4 (TAG-72)].
Maida Y; Kyo S; Inoue M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
[No Abstract] [Full Text] [Related]
14. Serum levels of tumor-associated glycoprotein (TAG-72) in digestive cancers.
Motoo Y; Satomura Y; Kawakami H; Watanabe H; Ohta H; Okai T; Sawabu N
Oncology; 1990; 47(6):456-62. PubMed ID: 2243663
[TBL] [Abstract][Full Text] [Related]
15. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
Sun G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818
[TBL] [Abstract][Full Text] [Related]
16. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
[TBL] [Abstract][Full Text] [Related]
17. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
[TBL] [Abstract][Full Text] [Related]
18. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
Filella X; Molina R; Jo J; Bedini JL; Joseph J; Ballesta AM
Bull Cancer; 1992; 79(3):271-7. PubMed ID: 1392166
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.
Esposito G; Panza N; Mansi L; De Matteis A; D'Aiuto G; Labonia V; Riccardi F; Pacilio G; Salvatore M
J Nucl Med Allied Sci; 1990; 34(2):88-93. PubMed ID: 2246676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
